Clinical aspects of epidermodysplasia verruciformis

Journal of the European Academy of Dermatology and Venereology

Volumn 17, Issue 4, 2003, Pages 394-398

  de Oliveira, Walmarroncalli R P ^a,b   Festa Neto, C ^a   Rady, P L ^b   Tyring, S K ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Epidermodysplasia verruciformis; Genodermatosis; Human papillomarivus; Skin cancer

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CANCER INVASION; CANCER MORTALITY; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL STUDY; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; EPIDERMODYSPLASIA VERRUCIFORMIS; FEMALE; FOREHEAD; GENODERMATOSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MALIGNANT TRANSFORMATION; METASTASIS; MULTIPLE CANCER; ONSET AGE; PRIORITY JOURNAL; SKIN TUMOR; SQUAMOUS CELL CARCINOMA; TUMOR LOCALIZATION; VIRUS INFECTION; WART VIRUS;

ADOLESCENT; ADULT; AGE DISTRIBUTION; BIOPSY, NEEDLE; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; DNA, VIRAL; EPIDERMODYSPLASIA VERRUCIFORMIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; INCIDENCE; MALE; PAPILLOMAVIRIDAE; PRECANCEROUS CONDITIONS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SAMPLING STUDIES; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; TIME FACTORS;

EID: 0038267379     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-3083.2003.00703.x     Document Type: Article

References (25)

1. Jablonska S. Epidermodysplasia verruciformis. In: Friedman RJ, Rigel DS, Kopf AW, Harris MN, Baker D, editors. Cancer of the Skin. W.B. Saunders, Philadelphia, 1991: 101-113.
2. Jablonska S, Majewski S. Epidermodysplasia verruciformis: Immunological and clinical aspects. Curr Top Microbiol Immunol 1994; 186: 157-175.
3. Kawashima M. Epidemodysplasia verruciformis. J Dermatol 1992; 19: 707-709.
4. Jablonska S. Epidermodysplasia verruciformis. In: Fitzpatrick TB, Eisen AW, Wolff K, Freedberg IN, Austen KF, editors. Dermatology in General Medicine. McGraw-Hill, New York, 1993: 2621-2667.
5. Jablonska S, Dabrowski J, Jakubowicz K. Epidermodysplasia verruciformis as a model in studies on the role of papovaviruses in oncogenesis. Cancer Res 1972; 2: 583-589.
6. Orth G, Jablonska S, Favre M, Croissant O, Jarbazek-Chorzelska M, Rzesa G. Characterization of two types of human papillomaviruses in lesions of epidermodysplasia verruciformis. Proc Natl Acad Sci USA 1978; 75: 1537-1541.
7. Orth G, Jablonska S, Jarzabeck-Chorzelska M et al. Characteristics of the lesions and risk of malignant conversion associated with the type of human papillomavirus involved in epidermodysplasia verruciformis. Cancer Res 1979; 39: 1074-1089.
8. Lutzner MA. Epidermodysplasia verruciformis. Bull Cancer 1978; 65: 169-182.
9. Jablonska S, Orth G, Jarbazek-Chorzelska M. Twenty-one years of follow-up studies of familial epidermodysplasia verruciformis. Dermatologica 1979; 158: 309-327.
10. Lutzner ME, Blanchet-Bardon C. Epidermodisplasia Verruciforme (Síndrome de Lewandosky-Lutz). In: Fitzpatrick TB, Wolff K, Freedberg IN, Austen KF, editors. Dermatologia en Medicina General. Panamericana, Buenos Aires, 1984: 2621-2634.
11. Majewski S, Jablonska S. Epidermodysplasia verruciformis as a model of human papillomavirus-induced genetic cancer of the skin. Arch Dermatol 1995; 131: 1312-1318.
12. Majewski S, Jablonska S. Epidermodysplasia verruciformis as a model of human papillomavirus-induced genetic cancers: the role of local immunosurveilance. Am J Med Sci 1992; 304: 174-179.
13. Majewski S, Jablonska S. Human papillomavirus-associated tumors of the skin and mucosa. J Am Acad Dermatol 1997; 36: 659-687.
14. Prawer SE, Pass F, Vance JC, Greenberg LJ, Yunis EJ, Zelickson AS. Depressed immune function in epidermodysplasia verruciformis. Arch Dermatol 1977; 113: 495-499.
15. Haftek M, Jablonska S, Orth G. Specific cell-mediated immunity in patients with epidermodysplasia veruciformis and plane warts. Dermatologica 1985; 170: 213-220.
16. Majewski S, Skopinska-Rosewska E, Jablonska S, Wasik M, Misiewick J, Orth G. Partial defects of cell-mediated immunity in patients with epidermodysplasia verruciformis. J Am Acad Dermatol 1986; 15: 966-973.
17. Majewski S, Jablonska S. Immunology of HPV infection and HPV-associated tumors. J Invest Dematol 1998; 37: 81-95.
18. Androphy EJ, Dvoretzky I, Lowy DR. X-Linked inheritance of epidermodysplasia verruciformis. Arch Dermatol 1985; 121: 864-868.
19. Rajagopalan K, Bahru J, Loo DSC, Tay CH, Chin KN, Tan KK. Familial epidermodysplasia verruciformis of Lewandowski and Lutz. Arch Dermatol 1972; 105: 73-78.
20. Lutzner MA, Blanchet-Bardon C. Epidermodysplasia verruciformis. Curr Probl Derm 1985; 13: 164-185.
21. Lutzner MA, Blanchet-Bardon C, Orth G. Clinical observations, virologic studies, and treatment trials in patients with epidermodysplasia verruciformis, a disease induced by specific human papillomaviruses. J Invest Dermatol 1984; 83: 18s-25s.
22. Tomasini C, Aloi F, Pippione M. Seborrheic keratosis-like lesions in epidermodysplasia verruciformis. J Cutan Pathol 1993; 20: 237-241.
23. Jacyk WK, Dreyer L, Villiers EM. Seborrheic keratoses of black patients with epidermoysplasia verruciformis contain human papillomavirus DNA. Am J Dermatophatol 1993; 15: 1-6.
24. Jablonska S, Obalek S, Orth G, Haftek M, Jarzabek-Chorzelska M. Regression of the lesions of epidermodysplasia verruciformis. Br J Dermatol 1982; 107: 109-116.
25. Boxmann ILA, Berkhout RJM, Mulder LHC et al. Detection of human papillomavirus DNA in plucked hairs from renal transplant recipients and healthy volunteers. J Invest Dermatol 1997; 108: 712-715.